Perioperative metformin use in patients undergoing total joint replacement surgery: protocol for a randomised, placebo-controlled pilot study
Authors:
Open Access
- 8 April 2025
- Vol. 15 (4) , e091446
Abstract
Introduction: Patients with poor perioperative glycaemic control after total joint arthroplasty are at an increased risk of complications, mortality, delayed return to function and increased costs of care. Although correction of hyperglycaemia has been shown to improve patient outcomes, there is a lack of consensus regarding optimal perioperative glucose management after total joint replacement surgery. This pilot study aims to assess the feasibility of performing a multicentre randomised controlled trial to investigate the effect of perioperative metformin use on glycaemic control in the setting of total joint arthroplasty. Methods and analysis: This blinded, placebo-controlled, pilot randomised controlled trial will enrol 40 participants aged 18–99 years undergoing total hip or knee arthroplasty at a single academic tertiary centre. Patients will be randomly allocated to two groups of 20 participants each and will receive metformin or a placebo, respectively, for 2 weeks preoperatively, continued on the day of surgery, and up to 2 days postoperatively. The primary outcome is a composite of four endpoints to assess study feasibility: timely recruitment, timely study drug administration, protocol adherence and retention. Secondary outcomes include perioperative glycaemic variability, sliding scale insulin utilisation, hospital length of stay and 90-day rates of infection, mortality and readmission. Analyses will be on an intention-to-treat basis. Ethics and dissemination: The protocol was approved by Oregon Health & Science University Institutional Review Board, STUDY00025798. Written informed consent will be obtained for study participation. Findings will be disseminated via publication in peer-reviewed journals and conference presentations. Trial registration number: NCT06280274.Keywords
This publication has 22 references indexed in Scilit:
- Long-term Trends in Antidiabetes Drug Usage in the U.S.: Real-world Evidence in Patients Newly Diagnosed With Type 2 DiabetesDiabetes Care, 2017
- Peri‐operative continuation of metformin does not improve glycaemic control in patients with type 2 diabetes: A randomized controlled trialDiabetes, Obesity and Metabolism, 2017
- Estimating the sample size for a pilot randomised trial to minimise the overall trial sample size for the external pilot and main trial for a continuous outcome variableStatistical Methods in Medical Research, 2015
- SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical TrialsAnnals of Internal Medicine, 2013
- Stress-Induced Hyperglycemia, Not Diabetic Hyperglycemia, Is Associated With Higher Mortality in TraumaAnnals of Surgery, 2012
- Perioperative Hyperglycemia and Postoperative Infection after Lower Limb ArthroplastyJournal of Diabetes Science and Technology, 2011
- Does Stress-Induced Hyperglycemia Increase the Risk of Perioperative Infectious Complications in Orthopaedic Trauma Patients?Journal of Orthopaedic Trauma, 2010
- Perioperative Management of Diabetes and Hyperglycemia in Patients Undergoing Orthopaedic SurgeryJournal of the American Academy of Orthopaedic Surgeons, 2010
- Prevalence and Clinical Outcome of Hyperglycemia in the Perioperative Period in Noncardiac SurgeryDiabetes Care, 2010
- A tutorial on pilot studies: the what, why and howBMC Medical Research Methodology, 2010